CoreCap Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5K Buy
23
+14
+156% +$2.33K ﹤0.01% 2379
2026
Q1
$1.89K Sell
9
-1
-10% -$251 ﹤0.01% 2423
2025
Q4
$2.84K Buy
10
+2
+25% +$625 ﹤0.01% 2379
2025
Q3
$2.47K Sell
8
-6
-43% -$1.88K ﹤0.01% 2338
2025
Q2
$4.4K Buy
14
+2
+17% +$577 ﹤0.01% 2147
2025
Q1
$3.15K Hold
12
﹤0.01% 2224
2024
Q4
$3.13K Buy
12
+8
+200% +$2.02K ﹤0.01% 2102
2024
Q3
$931 Hold
4
﹤0.01% 2281
2024
Q2
$807 Hold
4
﹤0.01% 1408
2024
Q1
$686 Buy
+4
New +$746 ﹤0.01% 2287

Other funds holding PODD

CoreCap Advisors's PODD Position: Q2 2026 in Review

CoreCap Advisors increased its Insulet (PODD) stake by 156% in Q2 2026, buying an estimated $2.33K and bringing the position to 23 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2379.

CoreCap Advisors first reported a position in PODD in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.4K in Q2 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • CoreCap Advisors held 23 shares of Insulet worth $3.5K as of Q2 2026.
  • CoreCap Advisors bought 14 Insulet shares in Q2 2026, an estimated $2.33K.
  • Insulet made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2379 holding.
  • CoreCap Advisors first reported a position in Insulet in Q1 2024 and has held it in 10 quarters since.
  • CoreCap Advisors's Insulet position peaked at $4.4K in Q2 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.